LSIPR 50 2016: Roy Waldron

05-10-2016

Roy Waldron was selected in the LSIPR 50 2016 publication for his influence on the life sciences industry. Waldron was featured in the legal section, as LSIPR reports.

roywaldron.jpg

Name: Roy Waldron

Organisation: Pfizer


Roy Waldron, Pfizer, associate general counsel, chief intellectual property counsel, GSK, Johnson & Johnson, Eli Lilly, Takeda, patent, trademark, legal,

LSIPR